Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Baas

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Chemotherapy for malignant mesotheliomaPaul Baas
Current Opinion in Oncology|March 7, 2002
Inductive and adjuvant treatment strategies for localized nonsmall cell lung cancer in operable and inoperable patientsPaul Baas
Lung Cancer (Amsterdam, Netherlands)|October 11, 2007
Optimising survival in malignant mesotheliomaPaul Baas
Seminars in Oncology|February 12, 2002
Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbinePaul Baas
Current Opinion in Oncology|February 26, 2003
Predictive and prognostic factors in malignant pleural mesotheliomaPaul Baas
Nature Reviews. Clinical Oncology|February 24, 2011
Diagnosis: ASTER--another flower in the diagnostic field of lung cancer?Paul Baas
Lung Cancer (Amsterdam, Netherlands)|June 1, 2012
Primum non nocere? Does this also apply to mesothelioma?Paul Baas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2021
Nivolumab Plus Ipilimumab Should Be the Standard of Care for First-Line Unresectable Epithelioid MesotheliomaPaul Baas
The Lancet. Oncology|June 18, 2018
Malignant pleural effusions: will PROMISE make its name true?Paul Baas, Sjaak Burgers
The Annals of Thoracic Surgery|June 30, 2004
Foscan-mediated photodynamic therapy and operation for malignant pleural mesotheliomaHugo Schouwink, Paul Baas
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Chemotherapy for malignant mesotheliomaPaul Baas
Current Opinion in Oncology|March 7, 2002
Inductive and adjuvant treatment strategies for localized nonsmall cell lung cancer in operable and inoperable patientsPaul Baas
Lung Cancer (Amsterdam, Netherlands)|October 11, 2007
Optimising survival in malignant mesotheliomaPaul Baas
Seminars in Oncology|February 12, 2002
Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbinePaul Baas
Current Opinion in Oncology|February 26, 2003
Predictive and prognostic factors in malignant pleural mesotheliomaPaul Baas
Nature Reviews. Clinical Oncology|February 24, 2011
Diagnosis: ASTER--another flower in the diagnostic field of lung cancer?Paul Baas
Lung Cancer (Amsterdam, Netherlands)|June 1, 2012
Primum non nocere? Does this also apply to mesothelioma?Paul Baas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2021
Nivolumab Plus Ipilimumab Should Be the Standard of Care for First-Line Unresectable Epithelioid MesotheliomaPaul Baas
The Lancet. Oncology|June 18, 2018
Malignant pleural effusions: will PROMISE make its name true?Paul Baas, Sjaak Burgers
The Annals of Thoracic Surgery|June 30, 2004
Foscan-mediated photodynamic therapy and operation for malignant pleural mesotheliomaHugo Schouwink, Paul Baas
Pageof 20